Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
03/2005
03/10/2005WO2003079987A3 A non-selective cation channel in neural cells and methods for treating brain swelling
03/10/2005WO2003076570A3 Antigens and their use as diagnostics and vaccines against species of plasmodium
03/10/2005WO2003073990A3 Treatment for asthma or allergies
03/10/2005WO2003073062A3 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors
03/10/2005WO2003072542A3 Interfacial biomaterials
03/10/2005WO2003065008A3 Methods and compositions for identification and therapeutic use of genes involved in vascular and proliferative diseases
03/10/2005WO2003065003A3 Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
03/10/2005WO2003062444A3 Array systems and methods
03/10/2005WO2003052425A3 Elisa kit for cyp 2c9 metabolic phenotypes
03/10/2005WO2003037167A9 Pathway of rantes-mediated chemokine synthesis in astrocytes and methods of use therefor
03/10/2005WO2003010290A3 Novel class ii cytokine receptors and uses thereof
03/10/2005WO2001011335A3 Antiviral compounds that inhibit viral replication
03/10/2005US20050055166 Nonlinear modeling of gene networks from time series gene expression data
03/10/2005US20050055165 Calculating a potential of mean force (PMF) score of a protein-ligand complex
03/10/2005US20050054943 Non-invasive, miniature, breath monitoring apparatus
03/10/2005US20050054936 Method and system for characterization and mapping of tissue lesions
03/10/2005US20050054839 Methods and apparatus for processing temperature sensitive materials
03/10/2005US20050054838 Recovering a calcium-sensitive luminescent protein via gradient elution chromatography
03/10/2005US20050054823 Genes
03/10/2005US20050054699 Skin disorders; vision defects; glandular disorders
03/10/2005US20050054680 Agonists and antagonists of 5h3-like receptors of invertebrates as pesticides
03/10/2005US20050054651 Compositions and methods for the treatment of disease associated with Trp-p8 expression
03/10/2005US20050054593 New drug
03/10/2005US20050054592 Alzheimer's disease; Parkinson's disease; isolated nucleic acids
03/10/2005US20050054591 Yin yang-1
03/10/2005US20050054585 Using saccharide; bone disorders
03/10/2005US20050054575 Peptide agonists of prostate-specific antigen and uses therefor
03/10/2005US20050054574 Using calcium channel blockers
03/10/2005US20050054573 Kit for detection, monitoring kinase, phosphatase; mixture of peptides; detectable compound; adjustment proteolytic sensitivity
03/10/2005US20050054565 Agonists and antagonists of moxifin for the treatment of metabolic disorders
03/10/2005US20050054118 High throughput screening method
03/10/2005US20050054117 Using concentration of macrophage migration inhibitory factor (MIF) in blood, urine or saliva as diagnostic indicator of stroke, heart attack and myocardial infarction; high throughput assay
03/10/2005US20050054114 Blood monitoring device comprised of tubed junctions for transfer and deposition of selected liquids and heat transfer elements; uniform fluidic circuit with heated reaction chamber that is not subject to plastic degradation at heat transfer surface
03/10/2005US20050054112 Analyzer with sample quality measurement, and method
03/10/2005US20050054108 Yeast membrane protein expression system and its application in drug screening
03/10/2005US20050054102 Culturing preferential stem cells and generating pancreatic beta cell tissues via transfection for use in treatment of diabetes, hyperglycemia, and/or impaired glucose tolerance; tissue engineering; regenerative medicine
03/10/2005US20050054097 Expansion of stem cells; prevent cell differentiation , gene expression
03/10/2005US20050054094 SPRR1A and axonal regeneration
03/10/2005US20050054093 Progenitor cell culture for use in regenerative medicine and treatment of heart, liver and pancreatic disorders; tissue engineering and repair
03/10/2005US20050054088 Isolating preferential membrane protein via adhesion and elution from colloidal silca plasma membrane; polypeptide identification via mass spectroscopy and bioinformatics
03/10/2005US20050054081 Analysis of temperature-dependent molecular configurations
03/10/2005US20050054080 Device for recovering and staining biological samples on microscope slides; heat induced epitope recovery
03/10/2005US20050054079 In situ heat induced antigen recovery and staining apparatus and method
03/10/2005US20050054050 Green fluorescent protein for use as diagnostic indicator of genic expression in transformed cells; genetic engineering
03/10/2005US20050054046 Evaluating safety, efficacy and biological properties of immunoglobulin receptors; immunotherapeutic agents
03/10/2005US20050054045 Novel G-protein coupled receptor
03/10/2005US20050054041 Kini-3 motor protein and methods for its use
03/10/2005US20050054036 Growth factor isoform
03/10/2005US20050054034 Polypeptide encoding by a polynucleotide; for detecting diseases; use in diagnosis and in identifying compounds that may be agonists, antagonists as biodrug treating diseases; host cell culturing
03/10/2005US20050054024 Fluorescent assays for protein kinases
03/10/2005US20050054022 Identifying compounds which modulate activity of fatty acid transport 5 (FATP5) for use in prevention and treatment of body weight, insulin resistance, dyslipidemia, fatty liver and cardiovascular disorders
03/10/2005US20050054021 Methods of assessing Crohn's disease patient phenotype by I2, OmpC and ASCA serologic response
03/10/2005US20050054020 Protein O-sulfonation
03/10/2005US20050054019 Human monoclonal antibody for use in the diagnosis prevention and treatment of cell proliferative disorders; immunotherapy; immunodiagnostics
03/10/2005US20050054018 Using cell cycle checkpoint activation modulators to prevent and treat cell proliferative disorders
03/10/2005US20050054017 Using phosphorylated p21-activated protein kinases (PAK) as diagnostic tool in identifying modulator for prevention and treatment of cell proliferative disorders
03/10/2005US20050054016 Determination of bone-sialoprotein in bodily fluids for oncological problems
03/10/2005US20050054014 in vitro diagnostic test kit for osteoarthritis or rheumatoid arthritis by detecting tissue specific biochemical markers such as derives from perlecan, bigylcan, decorin, fibrillin-1 or protocadherin, or a sequence from aggrecan, cartilage intermediate layer protein (CILP); immunoassay
03/10/2005US20050054013 Using purinergic receptor to identify modulators tor prevention and treatment of bone mass and/or bone mineral density disorders
03/10/2005US20050054012 Using homeobox repeat sequences as tool in detection and treatment of facial muscular disorders
03/10/2005US20050054011 Using mitochondrial proteins (BIT-1) and amino enhancer of split (AES) sequences as tools in identifying modulator for treatment of cell proliferative disorders
03/10/2005US20050054010 Using human ether-a-go-go related gene (hERG) membrane protein to identify agents for use in treatment and prevention of cardiovascular disorders; antiarrythmic agents
03/10/2005US20050054009 Agents that bind to and inhibit human cytochrome P450 2C19
03/10/2005US20050054008 Identifying modulators which control migration of nuclear receptor from nucleus to non-nuclear cell target; screening for agent which prevent and treat cell proliferative disorders
03/10/2005US20050054007 Specific binding proteins including antibodies which bind to the necrotic centre of tumours, and uses thereof
03/10/2005US20050054006 Reacting aldehyde with 2- or 4-methylpyridinium salt in presence of catalyst or microwave energy, to form fluorescent dyes which are useful as organelle-specific probes
03/10/2005US20050054005 Using protein expression profiles of leptins a nd autoantibodies to insulin as diagnostic indicators of pancreatic disorders
03/10/2005US20050054004 Propagating layered nanotube via heating and mixing CdS/ZnS stock solution; enhancing photoluminescence
03/10/2005US20050054002 Solid support comprising immobilized 14-3-3 protein or 14-3-3 antibodies for use in identification of non-conventional transmissible agents (NCTA); screening for bovine spongiform encephalopathy (BSE); veterinary medicine
03/10/2005US20050053999 Monitoring activity of biopolymers; obtain biopolymer structure, supply to computer, compare to contol; A database containing protein sequences and information regarding protein interactions is used to "teach" the machine
03/10/2005US20050053997 Synthesizing polynucleotide sequences based on model generated sequences; bioinformatics; directed evolution of proteins
03/10/2005US20050053996 Detecting trace quantities of a molecular target by exploiting a specific interaction between the target and two molecular probes; identifying restriction fragment length polymorphisms; gene expression analysis
03/10/2005US20050053995 Staphylococcus aureus genes and polypeptides
03/10/2005US20050053993 Uses of an endothelial cell receptor
03/10/2005US20050053992 Methods for screening cellular proliferation using isotope labels
03/10/2005US20050053989 Libraries of recombinant chimeric proteins
03/10/2005US20050053978 Pharmacophore model generation and use
03/10/2005US20050053977 Methods for treating lentivirus infections
03/10/2005US20050053973 Generating multimers from two or more discrete monomer domains for use in identifying immuno-domains and ligands; recombinant mosaic proteins and drug screening
03/10/2005US20050053970 Methods and compositions for identifying peptide aptamers capable of altering a cell phenotype
03/10/2005US20050053964 Oligonucleotide identifiers
03/10/2005US20050053961 Analysis system comprising structure of an ion-permeable passage connecting first AND second pools; molecular motor of processive nucleic acid translocation is not bacteriophage receptor; differentiation between hybridized nucleotide monomers before entering channel
03/10/2005US20050053958 Using allelic variation in breast cancer genes (BRCA) as diagnostic tool in detection of mammary gland cell proliferative disorders
03/10/2005US20050053954 Multicomponent protein microarrays
03/10/2005US20050053949 Biochip for proteomics applications
03/10/2005US20050053945 Nucleosides; bioconjugation; solid phase synthesis
03/10/2005US20050053944 Using microarray comprised of immobilized peptide nucleic acids as probes for detection of preferential DNA or RNA target sequences
03/10/2005US20050053943 Transmembrane protein for use in the diagnosis, detection, prevention and treatment of cell proliferative disorders; immunotherapy
03/10/2005US20050053939 Methods and compositions for enhancing detection in determinations employing cleavable electrophoretic tag reagents
03/10/2005US20050053935 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer
03/10/2005US20050053931 Method for the diagnosis and therapy of renal cell carcinoma
03/10/2005US20050053925 Epitopes; immunoglobulins; hybridomas; diagnostic kits
03/10/2005US20050053924 Immunoglobulin specific for lymphadenopathy associated viral epitopes p24 and p26 for use as disgnostic tool in detection of viral disease
03/10/2005US20050053923 Using pre-membrane and envelope glycoprotein as diagnostic indicator of flavivirus infection; viricides and vaccine development
03/10/2005US20050053920 Retrovirus from the HIV group and its use
03/10/2005US20050053919 Using negative-sense single stranded RNA viral sequences as diagnostic tool in detection of respiratory syncytial viral infection
03/10/2005US20050053918 Method of identifying peptides capable of binding to MHC molecules, peptides identified thereby and their uses
03/10/2005US20050053914 Nucleotide sequences coding hepatitis envelope protein for use as tool in detecting hepactocyte receptors; drug screening, viricides and treatment of viral diseases
03/10/2005US20050053913 Reverse two-hybrid systems
03/10/2005US20050053912 Methods for inducing reversible stasis
1 ... 2158 2159 2160 2161 2162 2163 2164 2165 2166 2167 2168 2169 2170 2171 2172 2173 2174 2175 2176 2177 2178 ... 3937